Trial Profile
DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 15 Apr 2015 Planned initiation date changed from 1 Oct 2014 to 1 Jun 2015, according to ClinicalTrials.gov record.
- 16 Sep 2014 New trial record